Pharmaseed Ltd

Innovative technology demands an innovative CRO. Founded in 2003, Pharmaseed is the largest Israel-based GLP-certified preclinical and early clinical CRO, providing preclinical, early clinical, and consulting services for medical device, biotechnology, and pharmaceutical companies. Pharmaseed also provides pre-formulation services for small and medium-size startups as well as companies in the idea and feasibility stages. Pharmaseeds core competencies include: - CNS (stroke, Parkinson's, Alzheimer's, schizophrenia, etc.), - Cancer (xenograft, orthotopic and human tissue samples) - Pain (neuropathic, acute, chronic) - Inflammation (acute, chronic) - Metabolism (diabetes, other) - Stem cell research - Cannabis With over 20 years of experience, the experienced...

Cns (ad,vd,stroke,schizophrenia,parkinson's),inflammation (acute,chronic),pain (neuropathic,acute,chronic),metabolism (diabetes,other),cancer (xenograft,orthotopic and human tissue samples),human specimens supplier,stem cells,cannabis,cro,preclinical cro,safety studies,efficacy studies,cell therapy,in vitro models,in vivo models,toxicity studies,pk/adme,glp,and glp-certified

Pharmaseed ltd operates in the Biotechnology research industry.

Pharmaseed ltd's revenue is 11m - 100m

Pharmaseed ltd has 11 - 50 employees.